Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study

Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study

IntroductionFew data about the safety of immune checkpoint inhibitors (ICIs) in the patients with solid tumor with Occult Hepatitis B Virus (OBI) are available. According to the Taormina Workshop on Occult HBV Infection Faculty Members we defined as potential-OBI (pOBI) the HBV DNA negativity with a...

Full description

Bibliographic Details
Main Authors: Angioletta Lasagna, Giuseppe Albi, Renato Maserati, Andrea Zuccarini, Mattia Quaccini, Fausto Baldanti, Paolo Sacchi, Raffaele Bruno, Paolo Pedrazzoli
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
occult hepatitis B
cancer
immunotherapy
reactivation
screening
real-life study
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1044098/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1044098/full

Similar Items